Search
Kalaris Therapeutics Inc
KLRSAdd to Watchlist
3.510USD
+0.030+0.86%
Close 07-31 16:00（ET）Quotes delayed by 15 min
80.70MMarket Cap
LossP/E TTM
KLRS Financials
See Kalaris Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.
Kalaris Therapeutics Inc Earnings Date
Latest Release
May 12, 2026
EPS / Forecast
-0.46/-0.52
Revenue / Forecast
--/0.00
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-2.85
98.95%
Analyst Rating
BUY
2026/08/01
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FAQs
What are the current assets of Kalaris Therapeutics Inc?
According to Kalaris Therapeutics Inc's FY2025 earnings report, its current assets were 118.81M, with a year-on-year change of 0.22.
What are the total assets of Kalaris Therapeutics Inc?
According to Kalaris Therapeutics Inc's FY2025 earnings report, its total assets of Kalaris Therapeutics Inc were 121.74M, with a year-on-year change of 2.69.
What are the total liabilities of Kalaris Therapeutics Inc?
According to Kalaris Therapeutics Inc's FY2025 earnings report, its total liabilities of Kalaris Therapeutics Inc were 42.92M, with a year-on-year change of 719.28.
What is the total equity of Kalaris Therapeutics Inc?
According to Kalaris Therapeutics Inc's FY2025 earnings report, its total equity of Kalaris Therapeutics Inc was 78.81M, with a year-on-year change of -30.44.
What is the net operating income of Kalaris Therapeutics Inc?
According to Kalaris Therapeutics Inc's FY2025 earnings report, its net operating income of Kalaris Therapeutics Inc was -46.15M, with a year-on-year change of 16.48.
What is the net investment of Kalaris Therapeutics Inc?
According to Kalaris Therapeutics Inc's FY2025 earnings report, its net investment of Kalaris Therapeutics Inc was -19.72M, with a year-on-year change of -120.76.
What is the net financing of Kalaris Therapeutics Inc?
According to Kalaris Therapeutics Inc's FY2025 earnings report, its net financing of Kalaris Therapeutics Inc was 155.01M, with a year-on-year change of 738028.57.
What is the Earnings Per Share (EPS) of Kalaris Therapeutics Inc?
According to Kalaris Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -2.85, with a year-on-year change of 98.95.
What is the net income of Kalaris Therapeutics Inc?
According to Kalaris Therapeutics Inc's FY2025 earnings report, its net income was -43.44M, with a year-on-year change of 26.09.
What is the Return on Equity (ROE) of Kalaris Therapeutics Inc?
According to Kalaris Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -45.22, with a year-on-year change of 0.32.
What is the Return on Assets (ROA) of Kalaris Therapeutics Inc?
According to Kalaris Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -36.16, with a year-on-year change of 4.84.
What is the operating profit of Kalaris Therapeutics Inc?
According to Kalaris Therapeutics Inc's FY2025 earnings report, its operating profit was -46.15M, with a year-on-year change of 16.48.